Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by PezDalatoYouon Nov 18, 2021 3:29pm
158 Views
Post# 34142425

RE:VERY questionable accounting costing us LARGE - "FIDUCIARY"?

RE:VERY questionable accounting costing us LARGE - "FIDUCIARY"?I assumed that the Baxter long-term payout had to do with revenue streams to meet Nas (err senior US exchange) listing requirements. Implying something nefarious sounds beechy. As does specifically pointing out our knew 52 week loe. I had my eureka moment after reading the Q3 PR...watching all the puzzle pieces fall into place... ; - )
<< Previous
Bullboard Posts
Next >>